1

1

1

Breakthrough innovation in the fight against pancreatic cancer

Breakthrough innovation in the fight against pancreatic cancer

CC&C is a Medtech start-up. We rely on the latest discoveries in the field of oncology and in particular mechanical oncology and mechanobiology, to develop a treatment against pancreatic cancer.

Learn more about our technology…

In 2016, we published our Proof of Concept in PlosOne. This experiment validated the action of mechanical stress on a grafted tumor in mice. This is the first time in the world that such a result is obtained on live animals, and not in cell cultures.

Today, our goal is to experimentally validate the action of our device on human pancreatic cancer grafted in mouse pancreas. To do this, we have initiated a partnership in a European consortium around the Bichat Faculty of Medicine in Paris, a world leader in Digestive Oncology.

Our medium-term strategy : to finish research within two years and move on to a human prototype, with the goal of a first human experiment in 2025.

15 + 2 =

CELL CONTRAINT & CANCER Centre Médical Madonuccia Av. Dr Noël Franchini 20090 Ajaccio

CELL CONTRAINT & CANCER Centre Médical Madonuccia Av. Dr Noël Franchini 20090 Ajaccio